Your account is not claimed yet. You can sign up with ORCID to claim your account.

Xiao-Ju Zhang (Xiaoju Zhang)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Venues

Journal of oncology

The clinical respiratory journal

Cell death & disease

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ziqi Wang, Li Yang, Wenqiang Wang, Huanhuan Zhou, Juan Chen, Zeheng Ma, Xiaoyan Wang, Quncheng Zhang, Haiyang Liu, Chao Zhou, Zhiping Guo, Xiao-Ju Zhang
Comparative immunological landscape between pre- and early-stage LUAD manifested as ground-glass nodules revealed by scRNA and scTCR integrated analysis. Cell communication and signaling : CCS 21 (1) (2023)
Shao-Feng Duan, Meng-Meng Zhang, Qian Dong, Bo Yang, Wei Liu, Xin Zhang, Hai-Lan Yu, Shi-Hui Zhang, Nazeer Hussain Khan, Dong-Dong Wu, Xiao-Ju Zhang, Shaofeng Duan
A Water-Soluble Hydrogen Sulfide Donor Suppresses the Growth of Hepatocellular Carcinoma via Inhibiting the AKT/GSK-3 β / β -Catenin and TGF- β /Smad2/3 Signaling Pathways. Journal of oncology 2023 (2023)
Shao-Feng Duan, Meng-Meng Zhang, Qian Dong, Bo Yang, Wei Liu, Xin Zhang, Hai-Lan Yu, Shi-Hui Zhang, Nazeer Hussain Khan, Dong-Dong Wu, Xiao-Ju Zhang, Shaofeng Duan
A Water-Soluble Hydrogen Sulfide Donor Suppresses the Growth of Hepatocellular Carcinoma via Inhibiting the AKT/GSK-3 β / β -Catenin and TGF- β /Smad2/3 Signaling Pathways. Journal of oncology 2023 (2023)
Li Yang, Li-Mian Cao, Xiao-Ju Zhang, Bo Chu
Targeting ferroptosis as a vulnerability in pulmonary diseases. Cell death & disease 13 (7) (2022)
Ziqi Wang, Jie Diao, Xingru Zhao, Zhiwei Xu, Xiao-Ju Zhang
Clinical and functional significance of a novel ferroptosis-related prognosis signature in lung adenocarcinoma. Clinical and translational medicine 11 (3) (2022)
Fan Zhang, Jia Wang, Xiaobo Wang, Nan Wei, Haiyang Liu, Xiao-Ju Zhang
CD146-mediated acquisition of stemness phenotype enhances tumour invasion and metastasis after EGFR-TKI resistance in lung cancer. The clinical respiratory journal 13 (1) (2019)

Xiao-Ju Zhang.css-eqlu8i{font-size:small;padding-left:4px;} (Xiaoju Zhang)

Publication Activity (10 Years)

Top Topics

Top Venues

Xiao-Ju Zhang (Xiaoju Zhang)